Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity.
Inonu University, Department of Ophthalmology, Malatya,Turkey.
Osman Melih
OM
Ceylan
Inonu University, Department of Ophthalmology, Malatya,Turkey.
Seyhan
S
Dikçi
Inonu University, Department of Ophthalmology, Malatya,Turkey.
Oğuzhan
O
Genc
Inonu University, Department of Ophthalmology, Malatya,Turkey.
Turgut
T
Yılmaz
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D006801:Humans; D007231:Infant, Newborn; D058449:Intravitreal Injections; D000069579:Ranibizumab; D012178:Retinopathy of Prematurity; D042461:Vascular Endothelial Growth Factor A
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D000069579:Ranibizumab